Presentation is loading. Please wait.

Presentation is loading. Please wait.

Hypertrophic Pulmonary Osteoarthropathy as a Paraneoplastic Manifestation of Lung Cancer  Takeo Ito, MD, Koichi Goto, MD, Kiyotaka Yoh, MD, Seiji Niho,

Published by정수 도 Modified over 5 years ago

Similar presentations

Presentation on theme: "Hypertrophic Pulmonary Osteoarthropathy as a Paraneoplastic Manifestation of Lung Cancer  Takeo Ito, MD, Koichi Goto, MD, Kiyotaka Yoh, MD, Seiji Niho,"— Presentation transcript:

1 Hypertrophic Pulmonary Osteoarthropathy as a Paraneoplastic Manifestation of Lung Cancer 
Takeo Ito, MD, Koichi Goto, MD, Kiyotaka Yoh, MD, Seiji Niho, MD, Hironobu Ohmatsu, MD, Kaoru Kubota, MD, Kanji Nagai, MD, Eishi Miyazaki, MD, Toshihide Kumamoto, MD, Yutaka Nishiwaki, MD  Journal of Thoracic Oncology  Volume 5, Issue 7, Pages (July 2010) DOI: /JTO.0b013e3181dc1f3c Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Bone scan of a lung cancer patient with HPO who underwent complete surgical resection of the lung cancer. The pathologic stage of the resected tumor was T2aN0M0, stage IB. A, Scan before the operation, performed on August 27, Note the bilateral localized uptake of the radionuclide at the wrist, femur, tibia, fibula, knee, and ankle. Abnormal uptake is observed along the cortical margins of the femur or tibia. B, Scan after surgery, performed on February 2, The abnormal uptake decreased, compared with the preoperative scan. The operation was performed on November 11, 2002. Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181dc1f3c) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Bone scan of a lung cancer patient with HPO who underwent chemotherapy. The clinical stage was T2bN2M1b, stage IV. The clinical response to treatment with chemotherapy was stable disease. A, Scan before chemotherapy, performed on January 5, Marked abnormal diffuse, strong uptake is seen in the lower extremities. Abnormal uptake is seen in both elbows and wrists. B, Scan after the second course of chemotherapy, performed on May 24, The abnormal uptake decreased. Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181dc1f3c) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Hypertrophic Pulmonary Osteoarthropathy as a Paraneoplastic Manifestation of Lung Cancer  Takeo Ito, MD, Koichi Goto, MD, Kiyotaka Yoh, MD, Seiji Niho,"

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Volume 96, Issue 5, Pages (November 1989)

Volume 96, Issue 5, Pages (November 1989)
Su K. Metcalfe, MD, MPH, Michael T

Su K. Metcalfe, MD, MPH, Michael T
Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,
Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.
Clinical Outcome of Chemoradiation Therapy in Patients with Limited-Disease Small Cell Lung Cancer with Ipsilateral Pleural Effusion  Seiji Niho, MD,

Clinical Outcome of Chemoradiation Therapy in Patients with Limited-Disease Small Cell Lung Cancer with Ipsilateral Pleural Effusion  Seiji Niho, MD,
Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?  Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?  Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,
Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.
Acute and Progressive Tracheal Stenosis after Proton Beam Therapy with Concurrent Chemotherapy for Non–Small Cell Lung Cancer  Yoshitaka Zenke, MD, Shigeki.

Acute and Progressive Tracheal Stenosis after Proton Beam Therapy with Concurrent Chemotherapy for Non–Small Cell Lung Cancer  Yoshitaka Zenke, MD, Shigeki.
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A

Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Acute and Progressive Tracheal Stenosis after Proton Beam Therapy with Concurrent Chemotherapy for Non–Small Cell Lung Cancer  Yoshitaka Zenke, MD, Shigeki.

Acute and Progressive Tracheal Stenosis after Proton Beam Therapy with Concurrent Chemotherapy for Non–Small Cell Lung Cancer  Yoshitaka Zenke, MD, Shigeki.
Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy  Apar Pataer, MD, PhD, Neda Kalhor,

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy  Apar Pataer, MD, PhD, Neda Kalhor,
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,
Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients  Hes A.P. Brokx, MD, Otto Visser, MD, PhD,

Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients  Hes A.P. Brokx, MD, Otto Visser, MD, PhD,

Similar presentations

Ads by Google